-
1
المؤلفون: Camille Hallez, Cristina M. Dorobantu, Mohamed S Bouzidi, Valérie Thiers, Vincent Lucansky, Jean-Pierre Vartanian, Xiongxiong Li, Simon Wain-Hobson, Raphael Gaudin, Rodolphe Suspène
المساهمون: Rétrovirologie moléculaire - Molecular Retrovirology, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Collège Doctoral, Sorbonne Université (SU), China National Biotec Group (CNBG), Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Viroclinics Biosciences B. V. [Rotterdam, Netherlands], Biomedical Center Martin [Slovaquie], Jessenius Medical Faculty [Commenius University, Slovaquie] (JFMED), Commenius University in Bratislava - Univerzita Komenského-Commenius University in Bratislava - Univerzita Komenského, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), This work was supported by grants from the Institut Pasteur and Centre National de la Recherche Scientifique. C.H. and M.S.B. were supported by the Allocation de Recherche du Ministère de la Recherche and Ligue contre le Cancer, respectively. X.L. was supported by a stipend from the Lanzhou Institute of Biological Products Co., Ltd, subsidiary company of China National Biotec Group Company Limited and by a stipend from the Pasteur-Paris University International PhD program. V.L. was supported by the Fondation pour la Recherche Medicale (project no. ING20160435328). C.D. was supported by an EMBO Long Term Fellowship (EMBO ALTF 1428–2016). The study of patients was sponsored by the French National Agency for research on AIDS and hepatitis (ANRS). This work has been published within the framework of IdEx Université de Strasbourg and has received funding from the French State via the French National Research Agency (ANR) as part of the program ‘Investissements d’avenir’ to R.G. This work was supported by an ATIP-AVENIR starting grant to R.G., We would like to thank S. Urban for providing HepG2-NTCP cells, P. Pineau and A. Marchio for the cirrhotic liver samples, M.-L. Michel and S. Pol for serum samples, C. Neuveut, P. Moreau, P. Maillard and B. Quioc for HBV infection, Y. Jacob for the HIF-1α and HIF-1β plasmids, J. Krijnse-Locker and C. Schmitt for electron microscopy immunolabelling and V. Caval, N. Frampton and J. McKeating for helpful discussions., Rétrovirologie moléculaire, Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Collège doctoral [Sorbonne universités], Vartanian, Jean-Pierre, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
المصدر: Nature Microbiology
Nature Microbiology, 2019, 4 (7), pp.1196-1207. ⟨10.1038/s41564-019-0405-x⟩
Nature Microbiology, Nature Publishing Group, 2019, 4 (7), pp.1196-1207. ⟨10.1038/s41564-019-0405-x⟩مصطلحات موضوعية: Liver Cirrhosis, viruses, [SDV]Life Sciences [q-bio], MESH: Virus Replication*/drug effects, Gene Expression, medicine.disease_cause, Virus Replication, Applied Microbiology and Biotechnology, chemistry.chemical_compound, Hypoxia, ComputingMilieux_MISCELLANEOUS, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, 0303 health sciences, MESH: Liver Cirrhosis/enzymology, Cytidine, Transfection, Cobalt, Hepatitis B, MESH: Cobalt/pharmacology, MESH: Deoxyribonuclease I/metabolism, Hepatitis B Core Antigens, 3. Good health, [SDV] Life Sciences [q-bio], Capsid, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Hypoxia-Inducible Factor 1, MESH: Deoxyribonuclease I/genetics, Microbiology (medical), Hepatitis B virus, MESH: Mutation, MESH: Gene Expression, MESH: Hepatitis B/enzymology, MESH: Hypoxia-Inducible Factor 1/metabolism, Immunology, Biology, Microbiology, Gene Expression Regulation, Enzymologic, Cell Line, 03 medical and health sciences, Genetics, medicine, Deoxyribonuclease I, Humans, MESH: Gene Expression Regulation, Enzymologic/drug effects, 030304 developmental biology, MESH: Hypoxia*/chemically induced, MESH: Humans, 030306 microbiology, Virion, MESH: Virion/metabolism, MESH: Hepatitis B Core Antigens/metabolism, Cell Biology, medicine.disease, Molecular biology, In vitro, MESH: Cell Line, MESH: DNA, Viral/metabolism, chemistry, DNA, Viral, Mutation, DNA, MESH: Hepatitis B virus/physiology
-
2Academic Journal
المؤلفون: Hallez, Camille, Li, Xiongxiong, Suspene, Rodolphe, Thiers, Valérie, Bouzidi, Mohamed, M Dorobantu, Cristina, Lucansky, Vincent, Wain-Hobson, Simon, Gaudin, Raphael, Vartanian, Jean Pierre
المساهمون: Rétrovirologie moléculaire - Molecular Retrovirology, Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Collège Doctoral, Sorbonne Université (SU), China National Biotec Group (CNBG), Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Viroclinics Biosciences B. V. Rotterdam, Netherlands, Biomedical Center Martin Slovaquie, Jessenius Medical Faculty Commenius University, Slovaquie (JFMED), Commenius University in Bratislava - Univerzita Komenského-Commenius University in Bratislava - Univerzita Komenského, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), This work was supported by grants from the Institut Pasteur and Centre National de la Recherche Scientifique. C.H. and M.S.B. were supported by the Allocation de Recherche du Ministère de la Recherche and Ligue contre le Cancer, respectively. X.L. was supported by a stipend from the Lanzhou Institute of Biological Products Co., Ltd, subsidiary company of China National Biotec Group Company Limited and by a stipend from the Pasteur-Paris University International PhD program. V.L. was supported by the Fondation pour la Recherche Medicale (project no. ING20160435328). C.D. was supported by an EMBO Long Term Fellowship (EMBO ALTF 1428–2016). The study of patients was sponsored by the French National Agency for research on AIDS and hepatitis (ANRS). This work has been published within the framework of IdEx Université de Strasbourg and has received funding from the French State via the French National Research Agency (ANR) as part of the program ‘Investissements d’avenir’ to R.G. This work was supported by an ATIP-AVENIR starting grant to R.G., We would like to thank S. Urban for providing HepG2-NTCP cells, P. Pineau and A. Marchio for the cirrhotic liver samples, M.-L. Michel and S. Pol for serum samples, C. Neuveut, P. Moreau, P. Maillard and B. Quioc for HBV infection, Y. Jacob for the HIF-1α and HIF-1β plasmids, J. Krijnse-Locker and C. Schmitt for electron microscopy immunolabelling and V. Caval, N. Frampton and J. McKeating for helpful discussions.
المصدر: ISSN: 2058-5276.
مصطلحات موضوعية: MESH: Cell Line, MESH: Cobalt/pharmacology, MESH: Humans, MESH: Hypoxia*/chemically induced, MESH: Hypoxia-Inducible Factor 1/metabolism, MESH: Liver Cirrhosis/enzymology, MESH: Mutation, MESH: Virion/metabolism, MESH: Virus Replication*/drug effects, MESH: DNA, Viral/metabolism, MESH: Deoxyribonuclease I/genetics, MESH: Deoxyribonuclease I/metabolism, MESH: Gene Expression, MESH: Gene Expression Regulation, Enzymologic/drug effects, MESH: Hepatitis B/enzymology, MESH: Hepatitis B Core Antigens/metabolism, MESH: Hepatitis B virus/physiology, [SDV]Life Sciences [q-bio], [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Relation: info:eu-repo/semantics/altIdentifier/pmid/30936483; pasteur-02424852; https://pasteur.hal.science/pasteur-02424852; PUBMED: 30936483